Hanseatic Management Services’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$648K Sell
1,836
-10
-0.5% -$3.68K 0.82% 44
2024
Q3
$662K Buy
+1,846
New +$624K 0.94% 40
2023
Q2
Sell
-1,997
Closed -$447K 141
2023
Q1
$447K Buy
+1,997
New +$492K 1.01% 38
2015
Q4
Sell
-4,097
Closed -$713K 399
2015
Q3
$713K Hold
4,097
0.22% 151
2015
Q2
$713K Buy
4,097
+3,610
+741% +$649K 0.32% 115
2015
Q1
$84K Buy
487
+36
+8% +$5.49K 0.04% 158
2014
Q4
$58K Buy
+451
New +$58.1K 0.03% 156

Other funds holding UTHR

Hanseatic Management Services's UTHR Position: Q4 2024 in Review

Hanseatic Management Services reduced its United Therapeutics (UTHR) stake by 0.54% in Q4 2024, selling an estimated $3.68K and leaving 1,836 shares worth $648K. The position accounts for 0.82% of the portfolio, ranked #44.

Hanseatic Management Services first reported a position in UTHR in Q4 2014 and has held it in 7 quarters since. The position peaked at $713K in Q3 2015. 673 funds tracked by Wall St. Rank hold UTHR as of Q4 2024.

  • Hanseatic Management Services held 1,836 shares of United Therapeutics worth $648K as of Q4 2024.
  • Hanseatic Management Services sold 10 United Therapeutics shares in Q4 2024, an estimated $3.68K.
  • United Therapeutics made up 0.82% of Hanseatic Management Services's portfolio in Q4 2024, its #44 holding.
  • Hanseatic Management Services first reported a position in United Therapeutics in Q4 2014 and has held it in 7 quarters since.
  • Hanseatic Management Services's United Therapeutics position peaked at $713K in Q3 2015.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2024.

Based on Hanseatic Management Services's 13F filing for Q4 2024, filed 15 Jan 2025.